HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk.

AbstractOBJECTIVE:
To investigate the association of the THBD c.1418C>T polymorphism, which encodes for the replacement of Ala455 by Val in thrombomodulin (TM), with venous thromboembolism (VTE), plasma soluble TM, and activated protein C levels. In addition, human umbilical vein endothelial cells (HUVEC) isolated from 100 umbilical cords were used to analyze the relation between this polymorphism and THBD mRNA and TM protein expression.
APPROACH AND RESULTS:
The THBD c.1418C>T polymorphism was genotyped in 1173 patients with VTE and 1262 control subjects. Levels of soluble TM and activated protein C were measured in 414 patients with VTE (not on oral anticoagulants) and 451 controls. HUVECs were genotyped for the polymorphism and analyzed for THBD mRNA and TM protein expression and for the ability to enhance protein C activation by thrombin. The 1418T allele frequency was lower in patients than in controls (P<0.001), and its presence was associated with a reduced VTE risk, reduced soluble TM levels, and increased circulating activated protein C levels (P<0.001). In cultured HUVEC, the 1418T allele did not influence THBD expression but was associated with increased TM in cell lysates, increased rate of protein C activation, and reduced soluble TM levels in conditioned medium.
CONCLUSIONS:
The THBD 1418T allele is associated with lower soluble TM, both in plasma and in HUVEC-conditioned medium, and with an increase in functional membrane-bound TM in HUVEC, which could explain the increased activated protein C levels and the reduced VTE risk observed in individuals carrying this allele.
AuthorsSilvia Navarro, Pilar Medina, Elena Bonet, Javier Corral, Vicenta Martínez-Sales, Laura Martos, Miguel Rivera, Esther Roselló-Lletí, Ignacio Alberca, Vanessa Roldán, Yolanda Mira, Fernando Ferrando, Amparo Estellés, Vicente Vicente, Rogier M Bertina, Francisco España
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 33 Issue 6 Pg. 1435-40 (Jun 2013) ISSN: 1524-4636 [Electronic] United States
PMID23520161 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Genetic Markers
  • Protein C
  • RNA, Messenger
  • Thrombomodulin
Topics
  • Adult
  • Alleles
  • Case-Control Studies
  • Cells, Cultured
  • Endothelial Cells
  • Female
  • Genetic Markers
  • Genetic Predisposition to Disease (epidemiology)
  • Genotype
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Polymorphism, Genetic
  • Protein C (genetics, metabolism)
  • RNA, Messenger (analysis)
  • Reference Values
  • Risk Assessment
  • Solubility
  • Thrombomodulin (genetics, metabolism)
  • Venous Thromboembolism (epidemiology, genetics)
  • Venous Thrombosis (epidemiology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: